- ISIN
- US05350V1061
- CUSIP
- 05350V106
- Delisting Date
- Jul 24, 2026
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Oct 21, 2014
Highlights
- Market Cap
- $1.17B
- Enterprise Value
- $1.26B
- EPS (TTM)
- -$2.24
- Total Revenue (TTM)
- $715.90M
- Gross Profit (TTM)
- $353.40M
- EBITDA (TTM)
- -$29.60M
- Year Range
- $9.30 - $25.49
- Target Price
- $23.00
- ROA (TTM)
- -6.61%
- ROE (TTM)
- -8.87%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
AVNS Performance Chart
Loading charts...
Compare this symbol against anything
Returns By Period
Avanos Medical, Inc. (AVNS) has returned 122.53% so far this year and 127.60% over the past 12 months. Over the last ten years, AVNS has returned -3.20% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Avanos Medical, Inc.
- 1D
- 0.00%
- 1M
- 0.24%
- 6M
- 87.61%
- YTD
- 122.53%
- 1Y
- 127.60%
- 3Y*
- 0.81%
- 5Y*
- -8.02%
- 10Y*
- -3.20%
- ALL TIME*
- -2.29%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
AVNS Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 18.61% | 5.86% | -0.64% | 75.73% | 0.73% | 0.32% | 0.44% | 122.53% | |||||
| 2025 | 8.17% | -12.60% | -4.78% | -12.42% | 0.16% | -2.63% | -8.74% | 6.89% | -3.18% | -3.89% | 5.67% | -4.34% | -29.46% |
| 2024 | -14.44% | -3.23% | 7.22% | -9.19% | 10.12% | 0.05% | 20.08% | 1.25% | -0.78% | -22.26% | 2.57% | -16.91% | -29.02% |
| 2023 | 13.23% | -8.39% | 5.95% | -0.67% | -17.06% | 4.33% | -4.26% | -14.02% | -3.90% | -9.20% | 17.37% | 4.08% | -17.11% |
| 2022 | -12.72% | 16.95% | -5.34% | -12.96% | -1.61% | -4.71% | 3.77% | -13.18% | -11.57% | 1.70% | 21.44% | 0.59% | -21.95% |
| 2021 | -1.26% | 1.50% | -4.87% | -1.21% | -7.20% | -9.30% | 4.32% | -13.02% | -5.45% | 1.09% | -4.34% | 14.92% | -24.43% |
Benchmark Metrics
Avanos Medical, Inc. has an annualized alpha of -7.00%, beta of 1.07, and R2 of 0.18 versus S&P 500 Index. Calculated based on daily prices since October 21, 2014.
- This stock participated in 148.55% of S&P 500 Index downside but only 85.35% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.18 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -7.00%
- Beta
- 1.07
- R²
- 0.18
- Upside Capture
- 85.35%
- Downside Capture
- 148.55%
Return for Risk
Risk / Return Rank
AVNS ranks 94 for risk / return — above 94% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVNS | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | +2.01 | ||
| Omega ratioGain probability vs. loss probability | 1.62 | 1.25 | +0.37 |
| Calmar ratioReturn relative to maximum drawdown | 6.61 | 2.00 | +4.61 |
| Martin ratioReturn relative to average drawdown | 14.84 | 8.49 | +6.34 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Avanos Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Avanos Medical, Inc. was 86.39%, occurring on Aug 5, 2025. The portfolio has not yet recovered.
The current Avanos Medical, Inc. drawdown is 65.60%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-86.39%Aug 2025 | 6y 11mo | — | 7y 11moSep 2018 - now | — |
-53.80%Feb 2016 | 10mo 8d | 2y 2mo | 3y 24dApr 2015 - May 2018 | — |
-12.63%Nov 2014 | 19d | 1mo 12d | 2mo 1dOct 2014 - Dec 2014 | — |
-10.83%Feb 2015 | 28d | 1mo 8d | 2mo 6dJan 2015 - Mar 2015 | — |
-9.56%Jul 2018 | 1mo 11d | 8d | 1mo 19dJun 2018 - Aug 2018 | — |
Drawdown Indicators
| AVNS | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.39% | -56.78% | -29.61% |
Max Drawdown (1Y)Largest decline over 1 year | -16.19% | -9.10% | -7.09% |
Max Drawdown (3Y)Largest decline over 3 years | -59.94% | -18.90% | -41.04% |
Max Drawdown (5Y)Largest decline over 5 years | -72.54% | -25.43% | -47.11% |
Max Drawdown (10Y)Largest decline over 10 years | -86.39% | -33.92% | -52.47% |
Current DrawdownCurrent decline from peak | -65.60% | -1.58% | -64.02% |
Average DrawdownAverage peak-to-trough decline | -47.25% | -10.70% | -36.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.44% | 2.14% | +5.30% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Avanos Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Avanos Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AVNS relative to other companies in the Medical Devices industry. Currently, AVNS has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with AVNS
Add Avanos Medical, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with AVNS